The long read sequencing market embraces diverse technologies, including single-molecule real-time sequencing, nanopore sequencing, synthetic long read sequencing, and more. Single-molecule real-time sequencing offers real-time data, nanopore sequencing utilizes nanopores for DNA analysis, while synthetic long read sequencing creates extended reads. These technologies collectively advance genomics by providing comprehensive, accurate, and varied sequencing approaches. The market's growth is fueled by these cutting-edge technologies' continuous evolution and integration, revolutionizing genomic research and applications.
Access full Report @ https://www.databridgemarketresearch.com/reports/north-america-long-read-sequencing-market
Data Bridge Market Research analyses that the North America Long Read Sequencing Market, which was USD 515.64 million in 2022, is expected to reach USD 3,305.5 million by 2030 and is expected to undergo a CAGR of 21.9% during the forecast period 2023-2030. Collaborations and partnerships between industry players and research institutions drive technological advancements in the long read sequencing market. This synergy fosters knowledge exchange, shared resources, and collective innovation, leading to the development of more sophisticated and effective sequencing technologies, thus positively impacting the market growth.
Key Findings of the Study
Escalating prevalence of genetic disorders is expected to drive the market's growth rate
The long read sequencing market is driven by the escalating prevalence of genetic disorders, necessitating advanced sequencing techniques. As genetic diseases become more widespread, there is a growing demand for precise and comprehensive genomic analysis, which long read sequencing technologies excel at providing. This increased need for accurate genetic information positions long read sequencing as a crucial tool in understanding and addressing genetic disorders, thus favoring market expansion.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Technology (Single-Molecule Real- Time Sequencing, Nanopore Sequencing, Synthetic Long Read Sequencing and Others), Product (Instruments, Consumables, and Services), Application (Whole Genome Sequencing, Epigenetics, RNA Sequencing, Complex Population, Targeted Sequencing, and Others), Workflow (Pre-Sequencing, Sequencing, and Data Analysis), End-User (Academic and Research Institutes, Clinical Laboratories, Hospitals, Pharma and Biotech Entities, and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America.
|
|
Market Players Covered
|
Illumina, Inc. (U.S.), MicrobesNG (U.S.), Roche Sequencing (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), PacBio (U.S.), Oxford Nanopore Technologies plc (U.K.), Quantapore, Inc. (U.S.), FG Technologies (Switzerland), BaseClearB.V (Netherlands), INSTITUTE OF INTEGRATIVE CELL BIOLOGY AND PHYSIOLOGY (France), The Garvan Institute (Australia), Génomique (France), Takara Holdings Inc. (Japan), Genexa AG (Switzerland)
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The North America long read sequencing market is segmented on the basis of technology, product, workflow, application, and end-user.
- On the basis of technology, the North America long read sequencing market is segmented into single-molecule real- time sequencing, nanopore sequencing, synthetic long read sequencing and others
- On the basis of product, the North America long read sequencing market is segmented into instruments, consumables and services
- On the basis of workflow, the North America long read sequencing market is segmented into pre-sequencing, sequencing, and data analysis
- On the basis of application, the North America long read sequencing market is segmented into whole genome sequencing, epigenetics, RNA sequencing, complex population, targeted sequencing, and others
- On the basis of end-user, the North America long read sequencing market is segmented into academic and research institutes, clinical laboratories, hospitals, pharma and biotech entities, and others
Major Players
Data Bridge Market Research recognizes the following companies as the North America long read sequencing market players in North America long read sequencing market are Illumina, Inc. (U.S.), MicrobesNG (U.S.), Roche Sequencing (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), PacBio (U.S.), Oxford Nanopore Technologies plc (U.K.).
Market Developments
- In 2023, Illumina launched the Illumina Complete Long Read Prep, Human assay, designed for high-performance human whole-genome sequencing. This advanced assay offers a comprehensive solution for researchers and genomic scientists. By providing an efficient and precise platform for long read sequencing, Illumina reinforces its commitment to advancing genomics research, enabling a deeper understanding of the human genome. The launch enhances Illumina's position in the genomics market, catering specifically to the evolving needs of human genome analysis
- In 2022, Oxford Nanopore Technologies launched the GridION X5 system, a notable development in the long read sequencing market. This system, known for its advanced nanopore sequencing technology, offers researchers a powerful tool for analyzing long DNA fragments. The GridION X5 system enhances the market landscape by providing efficient, real-time sequencing capabilities, contributing to the broader adoption of long read sequencing technologies and fostering advancements in genomics research and applications
- In 2020, Promega Corporation launched the Wizard HMW DNA Extraction Kit, catering to scientists handling large genomic DNA fragments. The 90-minute protocol allows researchers to acquire DNA fragments, enhancing long read sequencing performance. This strategic launch elevated Promega's product portfolio, making it more enticing and technologically advanced. The kit's efficiency addresses the evolving demands of genomics research, positioning Promega as a key player in providing solutions for improved genomic analysis and sequencing applications
Regional Analysis
Geographically, the countries covered in the North America long read sequencing market report are U.S., Canada and Mexico in North America.
As per Data Bridge Market Research analysis:
U.S. is the dominant country in the North America long read sequencing market during the forecast period 2023-2030
The U.S. dominates the long read sequencing market due to a substantial number of companies, robust R&D capabilities, and significant advancements in the field during the forecast period. The country's well-established infrastructure, research institutions, and continuous development initiatives contribute to its leadership. The confluence of these factors propels the U.S. to the forefront of long read sequencing technology, ensuring a prominent role in shaping the market's trajectory.
For more detailed information about the North America long read sequencing market report, click here – https://www.databridgemarketresearch.com/reports/north-america-long-read-sequencing-market
